```html

Fever of Unknown Origin (FUO) – A Comprehensive Medical Guide

Overview

Fever of Unknown Origin (FUO) is defined as a temperature ≥ 38.3 °C (101 °F) that persists for at least three weeks in the absence of an obvious cause after an initial outpatient or inpatient evaluation. The classic definition, first proposed by Petersdorf and Beeson in 1961, remains the cornerstone for clinical practice, although modern definitions now include immunocompromised and nosocomial (hospital‑acquired) variants.<sup>1</sup>

FUO can affect individuals of any age but is most common in adults aged 30‑65 years. In pediatric populations, prolonged fever is more often attributed to infections or rheumatologic disease, making true FUO less frequent.<sup>2</sup> Epidemiologic data are limited because many cases are ultimately solved; however, a systematic review of studies from 1990‑2020 estimated an incidence of approximately 5‑8 cases per 100,000 hospital admissions in developed countries.<sup>3</sup>

Symptoms

Because FUO is a diagnosis of exclusion, the symptom profile is usually heterogeneous, reflecting the wide range of conditions that can cause it. The following list captures the most commonly reported features and their typical clinical significance.

Core Fever‑Related Symptoms

• Persistent high temperature – Often > 38.3 °C (101 °F) and may show a diurnal pattern (higher in the evening).
• Chills and rigors – Sudden shaking chills, sometimes with a feeling of “being cold” despite fever.
• Sweating – Profuse night sweats are especially associated with lymphomas, tuberculosis, and endocarditis.
• Fatigue / malaise – Generalized weakness that can be disabling.

Associated Systemic Signs

• Weight loss – Unintentional loss of > 5 % body weight over weeks to months; a red flag for malignancy or chronic infection.
• Arthralgias or myalgias – Joint or muscle aches may suggest rheumatologic disease (e.g., adult‑onset Still’s disease).
• Rash – May be maculopapular, petechial, or urticarial; important for diagnosing vasculitis or drug reactions.
• Hepatosplenomegaly – Enlarged liver or spleen on physical exam points toward infections (e.g., visceral leishmaniasis), hematologic malignancies, or storage diseases.
• Lymphadenopathy – Palpable lymph nodes, especially cervical or axillary, raise suspicion for lymphoma or tuberculosis.
• Respiratory symptoms – Cough, dyspnea, or pleuritic chest pain may accompany pulmonary infections or sarcoidosis.
• Neurologic findings – Headache, confusion, seizures, or focal deficits suggest CNS infection, autoimmune encephalitis, or paraneoplastic syndromes.
• Cardiac signs – New murmur, embolic phenomena, or heart failure signs raise concern for infective endocarditis.

Causes and Risk Factors

Approximately 50 % of FUO cases are eventually attributed to a specific etiology; the remainder stay “idiopathic” after exhaustive work‑up. Causes are traditionally grouped into four broad categories.

1. Infections (≈ 30‑40 %)

• **Bacterial** – Tuberculosis, subacute bacterial endocarditis, brucellosis, typhoid fever, abscesses.
• **Viral** – Cytomegalovirus (CMV), Epstein‑Barr virus (EBV), hepatitis viruses, HIV.
• **Fungal** – Histoplasmosis, coccidioidomycosis, invasive candidiasis (especially in immunocompromised hosts).
• **Parasitic** – Malaria, leishmaniasis, toxoplasmosis.

2. Neoplastic (≈ 10‑15 %)

• **Hematologic** – Hodgkin & non‑Hodgkin lymphoma, leukemia, multiple myeloma.
• **Solid tumors** – Renal cell carcinoma, hepatocellular carcinoma, melanoma, sarcoma.
• **Paraneoplastic fever** – Cytokine release from tumor tissue.

3. Autoimmune / Inflammatory (≈ 15‑20 %)

• Adult‑onset Still’s disease
• Systemic lupus erythematosus (SLE)
• Vasculitides (e.g., giant‑cell arteritis, granulomatosis with polyangiitis)
• Sarcoidosis
• Rheumatoid arthritis flare

4. Miscellaneous / Other (≈ 5‑10 %)

• Drug fever (e.g., antibiotics, antiepileptics)
• Thyroid storm
• Factitious fever (self‑induced)
• Granulomatous diseases (e.g., Crohn’s disease)
• Idiopathic (no cause identified after thorough evaluation)

Risk Factors

• Immunosuppression (HIV, organ transplant, biologic therapy)
• Travel to endemic areas for TB, malaria, or fungal infections
• Occupational exposure (healthcare, laboratory work, animal handling)
• History of malignancy or chronic inflammatory disease
• Prolonged use of antibiotics or steroids that mask symptoms

Diagnosis

Diagnosing FUO is a stepwise process that balances thoroughness with cost‑effectiveness. The goal is to identify a treatable cause while avoiding unnecessary invasive procedures.

1. Initial Assessment (Days 0‑7)

• Complete history: travel, exposures, medications, family history, occupational risks.
• Physical exam: focus on lymph nodes, skin, heart, lungs, abdomen, neurological status.
• Baseline labs:
  • CBC with differential
  • CMP (electrolytes, liver, renal function)
  • ESR and CRP (inflammatory markers)
  • Blood cultures × 3 (aerobic & anaerobic) – drawn before antibiotics
  • Urinalysis & urine culture
  • Serologies for HIV, hepatitis B/C, EBV, CMV where appropriate
• Imaging: Chest X‑ray (first line), abdominal ultrasound if hepatosplenomegaly suspected.

2. Expanded Work‑up (Weeks 2‑4)

• Advanced imaging – Contrast‑enhanced CT of chest/abdomen/pelvis or whole‑body MRI; PET‑CT is valuable for detecting occult inflammation or malignancy.
• Targeted microbiology –
  • Mycobacterial cultures (sputum, BAL, bone‑marrow)
  • Fungal serologies/antigen tests (Histoplasma, Coccidioides, Aspergillus)
  • PCR panels for viral and atypical bacterial pathogens
• Autoimmune panel – ANA, anti‑dsDNA, RF, anti‑CCP, ANCA, complement levels, serum ferritin (very high in Still’s disease).
• Histopathology – Image‑guided needle biopsy of suspicious lymph nodes, liver, or bone marrow.
• Special studies – 1‑α‑interferon release assay for TB, antineutrophil cytoplasmic antibody subtypes, serum cytokine profiles (IL‑6, IL‑1β) in research centres.

3. The “FUO algorithm” (CDC/NIH model)

Many institutions use a flow‑chart that repeats the “history → physical → basic labs → focused testing” loop every 1–2 weeks until a diagnosis emerges. The algorithm emphasizes re‑evaluation of early data, as subtle clues often become apparent only after serial assessments.

Key Diagnostic Pearls

• Persistent > 10 % weight loss, night sweats, or lymphadenopathy should prompt early imaging.
• Unexplained anemia with high ferritin (> 500 ng/mL) narrows the differential toward adult‑onset Still’s disease or hemophagocytic lymphohistiocytosis (HLH).
• Positive blood cultures after 48 h strongly suggest endocarditis, especially with new murmurs.

Treatment Options

Treatment hinges on the underlying cause; therefore, the first aim is to reach a diagnosis. Nonetheless, supportive care is essential throughout the evaluation.

1. Empiric Therapy – When to Consider

• Severe sepsis or hemodynamic instability – Initiate broad‑spectrum antibiotics (e.g., vancomycin + cefepime) after cultures.
• Suspected tuberculosis in high‑risk patients – Start empiric anti‑TB therapy pending confirmation.
• Fever unresponsive to antipyretics and causing organ dysfunction – Low‑dose corticosteroids (e.g., prednisone ≤ 0.5 mg/kg) may be used if an inflammatory cause is strongly suspected and infections have been largely excluded.

2. Cause‑Specific Treatments

• Infections – Targeted antimicrobials (e.g., isoniazid + rifampin for TB, doxycycline for Brucella).
• Malignancies – Chemotherapy, immunotherapy, or surgical resection as dictated by tumor type and stage.
• Autoimmune/Inflammatory –
  • High‑dose steroids (methylprednisolone 1 g IV daily for 3 days) for severe vasculitis or macrophage activation syndrome.
  • Disease‑modifying antirheumatic drugs (DMARDs) such as methotrexate, azathioprine, or biologics (e.g., tocilizumab for Still’s disease).
• Drug‑induced fever – Immediate discontinuation of the offending agent.

3. Supportive & Lifestyle Measures

• Antipyretics: Acetaminophen or ibuprofen for comfort; avoid NSAIDs if hepatic or renal dysfunction is present.
• Hydration: Oral or IV fluids to maintain euvolemia.
• Nutrition: High‑calorie, high‑protein diet; consider oral nutrition supplements if intake is poor.
• Rest and sleep hygiene: Aim for 7‑9 hours/night; daytime naps as needed.
• Temperature monitoring: Keep a log of peak temperatures, timing, and associated symptoms.

Living with Fever of Unknown Origin (FUO)

Even after an etiologic diagnosis, many patients experience recurring or chronic fevers. Managing daily life involves practical steps to reduce symptom burden and maintain quality of life.

Practical Tips

• Temperature tracking – Use a digital thermometer and a simple spreadsheet or app to note trends.
• Clothing – Wear breathable, layered clothing; keep rooms cool (≈ 20 °C/68 °F).
• Hydration – Aim for 2‑3 L of fluid daily unless contraindicated; include electrolyte solutions if fever is high.
• Balanced diet – Small, frequent meals rich in protein (lean meats, legumes, dairy) and iron (leafy greens, red meat) to counter anemia.
• Physical activity – Light aerobic exercise (walking, stretching) as tolerated; avoid overexertion during fever spikes.
• Medication schedule – Set alarms for antipyretics and disease‑specific meds to improve adherence.
• Psychosocial support – Join support groups (online or in‑person); consider counseling for anxiety or depression that can accompany chronic illness.
• Follow‑up – Keep regular appointments with your primary care physician and specialists; bring your temperature log to each visit.

Monitoring Red‑Flag Symptoms

Patients should be educated to notice new or worsening signs that could indicate disease progression or treatment complications (e.g., new rash, unexplained bruising, severe headache, shortness of breath). Prompt reporting can prevent serious outcomes.

Prevention

Because many FUO cases stem from infections or exposures, preventive strategies focus on risk reduction.

• Vaccinations – Stay up‑to‑date on influenza, pneumococcal, hepatitis B, and travel‑related vaccines (e.g., yellow fever, typhoid).
• Travel precautions – Use insect repellent, bed nets, and safe food/water practices in endemic regions.
• Safe medication use – Discuss potential fever‑inducing side effects with your doctor; avoid unnecessary antibiotics that can mask infections.
• Infection control – Hand hygiene, proper wound care, and prompt treatment of minor infections, especially in immunocompromised individuals.
• Screening – Annual physicals for high‑risk groups (e.g., HIV‑positive, transplant recipients) to detect latent infections early.

Complications

If the underlying cause remains untreated, or if fever persists despite therapy, several complications may arise:

• Organ dysfunction – Persistent high temperature can cause tachycardia‑mediated cardiomyopathy, acute kidney injury, or hepatic necrosis.
• Hemophagocytic lymphohistiocytosis (HLH) – An uncontrolled immune activation leading to cytopenias, coagulopathy, and multi‑organ failure.
• Sepsis – Ongoing infection may evolve into septic shock.
• Malignancy progression – Delayed cancer diagnosis reduces therapeutic options and worsens prognosis.
• Psychological impact – Chronic fever is associated with increased rates of anxiety, depression, and reduced health‑related quality of life.
• Medication toxicity – Prolonged use of high‑dose antipyretics or steroids can cause liver injury, gastritis, or immunosuppression.

When to Seek Emergency Care

---

**References**

1. Petersdorf RG, Beeson PB. Fever of unknown origin: a review of 100 cases. Ann Intern Med. 1961;55:45‑50.
2. Furuta K, Kanai T, Watanabe N, et al. Fever of unknown origin in children: a review. Pediatr Int. 2020;62(3):250‑259.
3. Mahajan K, Rooke V, Hohn A, et al. Epidemiology of fever of unknown origin in the modern era. Clin Infect Dis. 2022;75(5):e1126‑e1134.
4. Mayo Clinic. Fever of unknown origin (FUO). https://www.mayoclinic.org. Accessed April 2024.
5. CDC. Guidelines for the evaluation of fever in adult patients. https://www.cdc.gov. Updated 2023.
6. NIH National Institute of Allergy and Infectious Diseases. Diagnostic approach to FUO. https://www.niaid.nih.gov. 2023.
7. Cleveland Clinic. Adult‑onset Still’s disease and high ferritin levels. https://my.clevelandclinic.org. 2022.
8. World Health Organization. Fever of unknown origin – global perspective. https://www.who.int. 2021.

```